Martin Schiller

Executive Director, Nevada Institute of Personalized Medicine
Professor of Life Sciences
Expertise: AIDS/HIV, Alzheimer's disease, Genetics, Bioinformatics, CRISPR gene editing

Biography

Martin Schiller's work is focused on short functional peptides, bioinformatics, and HIV. Schiller’s research has resulted in 60 publications supported mostly by 12 research grants from the National Institutes of Health.

He has received a number of awards, produced a suite of bioinformatics tools, and is involved in commercialization of some of his research projects. He is now the executive director of the Nevada Institute of Personalized Medicine.

Search For Other Experts On

biology, science & technology

Martin Schiller In The News

May 11, 2021
Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory. This joint project will make available the functional output of Variants of Unknown Significance throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase, a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.
May 11, 2021
Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory (JAX). This joint project will make available the functional output of Variants of Unknown Significance (VUS) throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase (CKB), a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.
August 6, 2020
The International Innovation Center @ Vegas (IIC@Vegas), a center for established and emerging tech companies developing smart technologies, announces a new tenant: Heligenics, Inc., a company founded to improve drug development, optimize clinical trial design and discover new diagnostics.
August 6, 2020
The International Innovation Center @ Vegas (IIC@Vegas), a center for established and emerging tech companies developing smart technologies, announces a new tenant: Heligenics, Inc., a company founded to improve drug development, optimize clinical trial design and discover new diagnostics.

Articles Featuring Martin Schiller

TJ Otzelberger at podium during news conference
Campus News | April 15, 2019
A collection of stories highlighting UNLV students and faculty who've made news thus far in 2019.
dna strand made of veggies atop a dinner plate with silverware at sides
Business and Community | January 16, 2019
Food Genes and Me is a site and software that lets users figure out health risks and how to solve them within minutes.
UNLV logo sign
Research | June 1, 2018
Funding from National Institutes of Health will support human genetics research, develop pipeline of scientists working to make Nevada a leader in personalized medicine.
Campus News | December 3, 2015
From law to health to advocacy to science, UNLV professors tackle HIV prevention, education and treatment both domestically and abroad.